ADmit THERAPEUTICS - test for an early AD detection. Alzheimer's disease
test for an early AD detectionAlzheimer's disease
test for an early AD detectionAlzheimer's disease  

Partners

Our main goal is to develop an early AD diagnosis test, to implement it in the clinical practice and to contribute to optimize patients’ recruitment in clinical trials. Our partners are essentials to reach our pipeline. We are currently supported by:
HORIZON 2020 This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 960327 HORIZON 2020
This website uses our own cookies and third-party cookies to collect information, in order to improve our services. Your continued use of this website constitutes acceptance of the installation of these cookies. The user has the option of configuring their browser in order to prevent cookies from being installed on their hard drive, although they must keep in mind that doing so may cause difficulties in their use of the webpage. I Agree  How to configure browser